Tag: PoNS
Helius announces US FDA 510(k) submission for PoNS device label expansion...
Helius Medical Technologies has announced the filing of its US Food and Drug Administration (FDA) 510(k) submission for the Portable Neuromodulation Stimulator (PoNS) device’s...
Neuromodulation device for treating MS-related gait deficit receives FDA authorisation
Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking" Portable Neuromodulation Stimulator (PoNS) device—developed for the short-term treatment of gait deficit due to...
Non-invasive PoNS device receives marketing authorisation from FDA
Helius Medical Technologies has announced that its Portable Neuromodulation Stimulator (PoNS) device, for multiple sclerosis sufferers, has received marketing authorisation from the US Food and...
